Cargando…

Views of the General Population on Newborn Screening for Spinal Muscular Atrophy in Japan

Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that results in progressive muscle atrophy and weakness. As new therapies for SMA have been developed, newborn screening for SMA can lead to early diagnosis and treatment. The objective of this study was to gather the general populati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Tomoko, Tokunaga, Sachi, Taniguchi, Naoko, Fujino, Tetsuro, Saito, Midori, Shimomura, Hideki, Takeshima, Yasuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391323/ https://www.ncbi.nlm.nih.gov/pubmed/34438585 http://dx.doi.org/10.3390/children8080694

Ejemplares similares

Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan
por: Kimizu, Tomokazu, et al.
Publicado: (2021)

PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan
por: Noguchi, Yoriko, et al.
Publicado: (2022)

Early Developmental Signs in Children with Autism Spectrum Disorder: Results from the Japan Environment and Children’s Study
por: Shimomura, Hideki, et al.
Publicado: (2022)

Effects of Screen Viewing Time on Sleep Duration and Bedtime in Children Aged 1 and 3 Years: Japan Environment and Children’s Study
por: Nishioka, Takafumi, et al.
Publicado: (2022)

A Pediatric Case of COLQ-Related Congenital Myasthenic Syndrome with Marked Fatigue
por: Horibe, Takuya, et al.
Publicado: (2023)

Correction: Noguchi et al. PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan. Genes 2022, 13, 2110
por: Noguchi, Yoriko, et al.
Publicado: (2023)

Newborn screening for spinal muscular atrophy: The views of affected families and adults
por: Boardman, Felicity K., et al.
Publicado: (2017)

Newborn screening for spinal muscular atrophy in Japan: One year of experience
por: Sawada, Takaaki, et al.
Publicado: (2022)

Newborn genetic screening for spinal muscular atrophy in the UK: The views of the general population
por: Boardman, Felicity K., et al.
Publicado: (2017)

Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment
por: Nishio, Hisahide, et al.
Publicado: (2023)

Spinal Muscular Atrophy Diagnosed by Newborn Screening
por: Lopez-Chacon, Matias, et al.
Publicado: (2019)

Relationship between growth and food avoidance with food allergy at age 3 years: The Japan Environment and Children's Study (JECS)
por: Saito, Midori, et al.
Publicado: (2023)

Interventions for spinal muscular atrophy: an impetus for newborn screening
Publicado: (2021)

Association between maternal insecticide use and otitis media in one-year-old children in the Japan Environment and Children’s Study
por: Utsunomiya, Takeshi, et al.
Publicado: (2022)

Detection of Spinal Muscular Atrophy Patients Using Dried Saliva Spots
por: Wijaya, Yogik Onky Silvana, et al.
Publicado: (2021)

Advances in Newborn Screening and Presymptomatic Diagnosis of Spinal Muscular Atrophy
por: Jędrzejowska, Maria
Publicado: (2020)

Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in England
por: Weidlich, Diana, et al.
Publicado: (2023)

Massachusetts’ Findings from Statewide Newborn Screening for Spinal Muscular Atrophy
por: Hale, Jaime E., et al.
Publicado: (2021)

Longitudinal developmental profile of newborns and toddlers treated for spinal muscular atrophy
por: Ngawa, Magali, et al.
Publicado: (2023)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
por: Niba, Emma Tabe Eko, et al.
Publicado: (2022)

Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening
por: Glascock, Jacqueline, et al.
Publicado: (2018)

Newborn Screening for Spinal Muscular Atrophy in China Using DNA Mass Spectrometry
por: Lin, Yiming, et al.
Publicado: (2019)

A call to introduce newborn screening for spinal muscular atrophy (SMA) in Scotland
por: Gillingwater, Thomas H., et al.
Publicado: (2022)

Landscape of Spinal Muscular Atrophy Newborn Screening in the United States: 2018–2021
por: Hale, Kshea, et al.
Publicado: (2021)

Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screening
por: Pane, Marika, et al.
Publicado: (2022)

Two closely spaced mutations in cis result in Ullrich congenital muscular dystrophy
por: Shimomura, Hideki, et al.
Publicado: (2019)

High Concentration or Combined Treatment of Antisense Oligonucleotides for Spinal Muscular Atrophy Perturbed SMN2 Splicing in Patient Fibroblasts
por: Wijaya, Yogik Onky Silvana, et al.
Publicado: (2022)

Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)

Spinal Muscular Atrophy and Ependymoma
por: Albakr, Aishah, et al.
Publicado: (2017)

Risdiplam for spinal muscular atrophy
Publicado: (2022)

A Novel System for Spinal Muscular Atrophy Screening in Newborns: Japanese Pilot Study
por: Shinohara, Masakazu, et al.
Publicado: (2019)

Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years
por: Vill, Katharina, et al.
Publicado: (2021)

Technical feasibility of newborn screening for spinal muscular atrophy by next-generation DNA sequencing
por: Shum, Bennett O. V., et al.
Publicado: (2023)

Pilot Program of Newborn Screening for 5q Spinal Muscular Atrophy in the Russian Federation
por: Mikhalchuk, Kristina, et al.
Publicado: (2023)

Spinal Muscular Atrophy Treatment in Patients Identified by Newborn Screening—A Systematic Review
por: Aragon-Gawinska, Karolina, et al.
Publicado: (2023)

Integrating newborn screening for spinal muscular atrophy into health care systems: an Australian pilot programme
por: D'Silva, Arlene M, et al.
Publicado: (2021)

Addressing the implementation gap in advanced therapeutics for spinal muscular atrophy in the era of newborn screening programs
por: Leon-Astudillo, Carmen, et al.
Publicado: (2022)

Spinal Muscular Atrophy Type I With False Negative in Newborn Screening: A Case Report
por: Hashimoto, Kazuhiko, et al.
Publicado: (2023)

Alberta Spinal Muscular Atrophy Newborn Screening—Results from Year 1 Pilot Project
por: Niri, Farshad, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gfb2lt4snsjhghkmm71hi8o0up